State of Illinois
91st General Assembly
Legislation

   [ Search ]   [ Legislation ]
[ Home ]   [ Back ]   [ Bottom ]



91_HB1789

 
                                               LRB9104988ACtm

 1        AN ACT to amend the Pharmacy  Practice  Act  of  1987  by
 2    changing Section 3.

 3        Be  it  enacted  by  the People of the State of Illinois,
 4    represented in the General Assembly:

 5        Section 5.  The Pharmacy Practice Act of 1987 is  amended
 6    by changing Section 3 as follows:

 7        (225 ILCS 85/3) (from Ch. 111, par. 4123)
 8        Sec. 3. Definitions.  For the purpose of this Act, except
 9    where otherwise limited therein:
10        (a)  "Pharmacy"  or  "drugstore" means and includes every
11    store,  shop,  pharmacy  department,  or  other  place  where
12    pharmaceutical care is provided by  a  pharmacist  (1)  where
13    drugs,  medicines,  or poisons are dispensed, sold or offered
14    for sale at retail, or displayed for sale at retail;  or  (2)
15    where  prescriptions  of physicians, dentists, veterinarians,
16    podiatrists,  or  therapeutically   certified   optometrists,
17    within  the limits of their licenses, are compounded, filled,
18    or dispensed; or (3) which has upon it  or  displayed  within
19    it,  or  affixed  to  or  used  in connection with it, a sign
20    bearing  the  word   or   words   "Pharmacist",   "Druggist",
21    "Pharmacy", "Pharmaceutical Care", "Apothecary", "Drugstore",
22    "Medicine  Store",  "Prescriptions", "Drugs", "Medicines", or
23    any word or words of similar or like import,  either  in  the
24    English  language  or  any  other  language; or (4) where the
25    characteristic prescription sign (Rx) or  similar  design  is
26    exhibited;  or  (5)  any  store, or shop, or other place with
27    respect to which any of the above words,  objects,  signs  or
28    designs are used in any advertisement.
29        (b)  "Drugs"  means  and includes (l) articles recognized
30    in  the   official   United   States   Pharmacopoeia/National
31    Formulary  (USP/NF),  or  any  supplement  thereto  and being
 
                            -2-                LRB9104988ACtm
 1    intended for and having for their  main  use  the  diagnosis,
 2    cure,  mitigation,  treatment or prevention of disease in man
 3    or other animals, as approved by the United States  Food  and
 4    Drug  Administration,  but  does not include devices or their
 5    components, parts, or accessories; and (2) all other articles
 6    intended for and having for their  main  use  the  diagnosis,
 7    cure,  mitigation,  treatment or prevention of disease in man
 8    or other animals, as approved by the United States  Food  and
 9    Drug  Administration,  but  does not include devices or their
10    components, parts, or accessories; and  (3)  articles  (other
11    than  food)  having for their main use and intended to affect
12    the structure or any function of the body  of  man  or  other
13    animals;  and  (4)  articles  having  for  their main use and
14    intended for use as a component or any articles specified  in
15    clause (l), (2) or (3); but does not include devices or their
16    components, parts or accessories.
17        (c)  "Medicines"  means  and  includes all drugs intended
18    for human or veterinary use approved  by  the  United  States
19    Food and Drug Administration.
20        (d)  "Practice   of  pharmacy"  means  the  provision  of
21    pharmaceutical  care  to  patients  as  determined   by   the
22    pharmacist's  professional  judgment  in the following areas,
23    which  may  include  but  are  not  limited  to  (1)  patient
24    counseling,  (2)  interpretation   and   assisting   in   the
25    monitoring  of  appropriate  drug  use  and  prospective drug
26    utilization  review,  (3)  providing   information   on   the
27    therapeutic   values,   reactions,  drug  interactions,  side
28    effects, uses, selection of medications and medical  devices,
29    and  outcome  of  drug  therapy,  (4)  participation  in drug
30    selection,  drug   monitoring,   drug   utilization   review,
31    evaluation,  administration,  interpretation,  application of
32    pharmacokinetic  and  laboratory  data  to  design  safe  and
33    effective drug regimens,  (5)  drug  research  (clinical  and
34    scientific),  and (6) compounding and dispensing of drugs and
 
                            -3-                LRB9104988ACtm
 1    medical devices.
 2        (e)  "Prescription" means and includes any written, oral,
 3    facsimile, or electronically transmitted order for  drugs  or
 4    medical  devices,  issued by a physician licensed to practice
 5    medicine in  all  its  branches,  dentist,  veterinarian,  or
 6    podiatrist,  or therapeutically certified optometrist, within
 7    the  limits  of  their  licenses, by a physician assistant in
 8    accordance with  subsection  (f)  of  Section  4,  or  by  an
 9    advanced  practice nurse in accordance with subsection (g) of
10    Section 4, containing the following: (l) name of the patient;
11    (2) date when prescription was issued; (3) name and  strength
12    of  drug or description of the medical device prescribed; and
13    (4) quantity, (5) directions for use, (6) prescriber's  name,
14    address and signature, and (7) DEA number where required, for
15    controlled  substances.  DEA numbers shall not be required on
16    inpatient drug orders.
17        (f)  "Person"  means  and  includes  a  natural   person,
18    copartnership,  association,  corporation, government entity,
19    or any other legal entity.
20        (g)  "Department" means the  Department  of  Professional
21    Regulation.
22        (h)  "Board of Pharmacy" or "Board" means the State Board
23    of Pharmacy of the Department of Professional Regulation.
24        (i)  "Director"   means   the  Director  of  Professional
25    Regulation.
26        (j)  "Drug product selection" means the interchange for a
27    prescribed pharmaceutical product in accordance with  Section
28    25  of  this  Act and Section 3.14 of the Illinois Food, Drug
29    and Cosmetic Act.
30        (k)  "Inpatient drug order" means an order issued  by  an
31    authorized prescriber for a resident or patient of a facility
32    licensed  under  the  Nursing  Home  Care Act or the Hospital
33    Licensing Act, or the University of Illinois Hospital Act "An
34    Act  in  relation  to  the  founding  and  operation  of  the
 
                            -4-                LRB9104988ACtm
 1    University of Illinois Hospital and the conduct of University
 2    of Illinois health care programs", approved July 3, 1931,  as
 3    amended, or a facility which is operated by the Department of
 4    Human  Services  (as  successor  to  the Department of Mental
 5    Health and Developmental Disabilities) or the  Department  of
 6    Corrections.
 7        (k-5)  "Pharmacist"   means   an   individual   currently
 8    licensed by this State to engage in the practice of pharmacy.
 9        (l)  "Pharmacist in charge" means the licensed pharmacist
10    whose  name  appears on a pharmacy license who is responsible
11    for all aspects of the operation related to the  practice  of
12    pharmacy.
13        (m)  "Dispense"  means  the delivery of drugs and medical
14    devices, in accordance with applicable State and federal laws
15    and  regulations,   to   the   patient   or   the   patient's
16    representative   authorized   to   receive   these  products,
17    including the compounding, packaging, and labeling  necessary
18    for delivery, and any recommending or advising concerning the
19    contents  and therapeutic values and uses thereof. "Dispense"
20    does not mean  the  physical  delivery  to  a  patient  or  a
21    patient's  representative  in  a  home  or  institution  by a
22    designee of a pharmacist or by  common  carrier.   "Dispense"
23    also does not mean the physical delivery of a drug or medical
24    device   to  a  patient  or  patient's  representative  by  a
25    pharmacist's designee within a pharmacy  or  drugstore  while
26    the pharmacist is on duty and the pharmacy is open.
27        (n)  "Mail-order  pharmacy"  means  a  pharmacy  that  is
28    located in a state of the United States, other than Illinois,
29    that  delivers,  dispenses or distributes, through the United
30    States Postal Service or other common  carrier,  to  Illinois
31    residents, any substance which requires a prescription.
32        (o)  "Compounding"   means   the   preparation,   mixing,
33    assembling,  packaging,  or  labeling  of  a  drug or medical
34    device: (1) as the result of  a  practitioner's  prescription
 
                            -5-                LRB9104988ACtm
 1    drug  order  or  initiative  that  is dispensed pursuant to a
 2    prescription in the course of professional practice;  or  (2)
 3    for  the  purpose  of, or incident to, research, teaching, or
 4    chemical analysis; or (3)  in  anticipation  of  prescription
 5    drug  orders based on routine, regularly observed prescribing
 6    patterns.
 7        (p)  "Confidential   information"   means    information,
 8    maintained  by  the  pharmacist  in  the  patient's  records,
 9    released  only (i) to the patient or, as the patient directs,
10    to other practitioners and other pharmacists or (ii)  to  any
11    other person authorized by law to receive the information.
12        (q)  "Prospective   drug  review"  or  "drug  utilization
13    evaluation" means a  screening  for  potential  drug  therapy
14    problems   due   to   therapeutic  duplication,  drug-disease
15    contraindications, drug-drug interactions (including  serious
16    interactions with nonprescription or over-the-counter drugs),
17    drug-food  interactions, incorrect drug dosage or duration of
18    drug treatment, drug-allergy interactions, and clinical abuse
19    or misuse.
20        (r)  "Patient counseling" means the communication between
21    a  pharmacist  or  a  student  pharmacist  under  the  direct
22    supervision of a pharmacist and a patient  or  the  patient's
23    representative  about  the patient's medication or device for
24    the  purpose  of  optimizing  proper  use   of   prescription
25    medications   or  devices.   The  offer  to  counsel  by  the
26    pharmacist  or  the  pharmacist's  designee,  and  subsequent
27    patient counseling by the pharmacist or  student  pharmacist,
28    shall  be  made  in  a  face-to-face  communication  with the
29    patient  or   patient's   representative   unless,   in   the
30    professional  judgment  of  the  pharmacist,  a  face-to-face
31    communication  is  deemed  inappropriate  or unnecessary.  In
32    that instance, the offer to counsel or patient counseling may
33    be made in a written communication, by  telephone,  or  in  a
34    manner determined by the pharmacist to be appropriate.
 
                            -6-                LRB9104988ACtm
 1        (s)  "Patient  profiles" or "patient drug therapy record"
 2    means the obtaining, recording, and  maintenance  of  patient
 3    prescription and personal information.
 4        (t)  "Pharmaceutical  care"  includes, but is not limited
 5    to, the act of monitoring drug use  and  other  patient  care
 6    services  intended  to  achieve  outcomes  that  improve  the
 7    patient's  quality  of life but shall not include the sale of
 8    over-the-counter drugs by a seller of goods and services  who
 9    does not dispense prescription drugs.
10        (u)  "Medical  device"  means  an  instrument, apparatus,
11    implement, machine, contrivance, implant, in  vitro  reagent,
12    or  other similar or related article, including any component
13    part or accessory, required under federal  law  to  bear  the
14    label  "Caution: Federal law requires dispensing by or on the
15    order of a physician". A seller of goods  and  services  who,
16    only  for  the  purpose  of  retail  sales, compounds, sells,
17    rents, or  leases  medical  devices  shall  not,  by  reasons
18    thereof, be required to be a licensed pharmacy.
19    (Source: P.A.  89-202,  eff.  7-21-95;  89-507,  eff. 7-1-97;
20    90-116, eff. 7-14-97;  90-253,  eff.  7-29-97;  90-655,  eff.
21    7-30-98; 90-742, eff. 8-13-98.)

[ Top ]